Kulkarni Shilpa, Koller Antonius, Mani Kartik M, Wen Ruofeng, Alfieri Alan, Saha Subhrajit, Wang Jian, Patel Purvi, Bandeira Nuno, Guha Chandan, Chen Emily I
Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York.
Proteomics Center, Stony Brook University School of Medicine, Stony Brook, New York; Proteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, New York, New York.
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):566-77. doi: 10.1016/j.ijrobp.2016.06.008. Epub 2016 Jun 18.
Early and accurate assessment of radiation injury by radiation-responsive biomarkers is critical for triage and early intervention. Biofluids such as urine and serum are convenient for such analysis. Recent research has also suggested that exosomes are a reliable source of biomarkers in disease progression. In the present study, we analyzed total urine proteome and exosomes isolated from urine or serum for potential biomarkers of acute and persistent radiation injury in mice exposed to lethal whole body irradiation (WBI).
For feasibility studies, the mice were irradiated at 10.4 Gy WBI, and urine and serum samples were collected 24 and 72 hours after irradiation. Exosomes were isolated and analyzed using liquid chromatography mass spectrometry/mass spectrometry-based workflow for radiation exposure signatures. A data dependent acquisition and SWATH-MS combined workflow approach was used to identify significantly exosome biomarkers indicative of acute or persistent radiation-induced responses. For the validation studies, mice were exposed to 3, 6, 8, or 10 Gy WBI, and samples were analyzed for comparison.
A comparison between total urine proteomics and urine exosome proteomics demonstrated that exosome proteomic analysis was superior in identifying radiation signatures. Feasibility studies identified 23 biomarkers from urine and 24 biomarkers from serum exosomes after WBI. Urinary exosome signatures identified different physiological parameters than the ones obtained in serum exosomes. Exosome signatures from urine indicated injury to the liver, gastrointestinal, and genitourinary tracts. In contrast, serum showed vascular injuries and acute inflammation in response to radiation. Selected urinary exosomal biomarkers also showed changes at lower radiation doses in validation studies.
Exosome proteomics revealed radiation- and time-dependent protein signatures after WBI. A total of 47 differentially secreted proteins were identified in urinary and serum exosomes. Together, these data showed the feasibility of defining biomarkers that could elucidate tissue-associated and systemic response caused by high-dose ionizing radiation. This is the first report using an exosome proteomics approach to identify radiation signatures.
通过辐射反应性生物标志物对辐射损伤进行早期准确评估对于分诊和早期干预至关重要。尿液和血清等生物流体便于进行此类分析。最近的研究还表明,外泌体是疾病进展中生物标志物的可靠来源。在本研究中,我们分析了从尿液或血清中分离的总尿蛋白质组和外泌体,以寻找接受致死性全身照射(WBI)的小鼠急性和持续性辐射损伤的潜在生物标志物。
为进行可行性研究,小鼠接受10.4 Gy的WBI照射,并在照射后24小时和72小时收集尿液和血清样本。使用基于液相色谱质谱/质谱的工作流程分离并分析外泌体,以寻找辐射暴露特征。采用数据依赖采集和SWATH-MS联合工作流程方法来鉴定指示急性或持续性辐射诱导反应的显著外泌体生物标志物。为进行验证研究,小鼠接受3、6、8或10 Gy的WBI照射,并对样本进行分析以作比较。
总尿蛋白质组学与尿外泌体蛋白质组学的比较表明,外泌体蛋白质组分析在识别辐射特征方面更具优势。可行性研究在WBI后从尿液中鉴定出23种生物标志物,从血清外泌体中鉴定出24种生物标志物。尿外泌体特征识别出的生理参数与血清外泌体中获得的不同。尿液中的外泌体特征表明肝脏、胃肠道和泌尿生殖道受到损伤。相比之下,血清显示出辐射引起的血管损伤和急性炎症。在验证研究中,选定的尿外泌体生物标志物在较低辐射剂量下也显示出变化。
外泌体蛋白质组学揭示了WBI后辐射和时间依赖性的蛋白质特征。在尿和血清外泌体中总共鉴定出47种差异分泌蛋白。总之,这些数据表明了定义生物标志物以阐明高剂量电离辐射引起的组织相关和全身反应的可行性。这是第一份使用外泌体蛋白质组学方法识别辐射特征的报告。